Related Experiment Video

Updated: Apr 7, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

[Advanced hepatocellular carcinoma: importance of clinical trials]

V Aedo, V Cristina, E Raymond

    Revue Medicale Suisse
    |July 9, 2015
    PubMed

    Insights

    Sorafenib is the primary targeted therapy for advanced hepatocellular carcinoma, inhibiting tumor vascularization. Ongoing research seeks new treatments to complement sorafenib for liver cancer patients.

    Area of Science:

    • Hepatocellular carcinoma (HCC) research
    • Oncology
    • Targeted cancer therapy

    Background:

    • Sorafenib is the sole validated medical treatment for hepatocellular carcinoma.
    • It functions as a targeted therapy, primarily inhibiting tumor vascularization.
    • Sorafenib is indicated for inoperable, advanced, or recurrent HCC stages.

    Purpose of the Study:

    • To review the current role of sorafenib in hepatocellular carcinoma treatment.
    • To highlight the need for additional therapeutic options beyond sorafenib.
    • To discuss ongoing clinical trials exploring novel antitumor agents for HCC.

    Main Methods:

    • Literature review of sorafenib's efficacy in hepatocellular carcinoma.
    • Analysis of current clinical trial landscape for HCC therapeutics.
    • Examination of sorafenib's mechanism of action in tumor vascularization.

    Main Results:

    • Sorafenib remains the cornerstone therapy for advanced and inoperable HCC.
    • Its efficacy is linked to its anti-angiogenic properties.
    • Limited treatment options exist, emphasizing the need for new drugs.

    Conclusions:

    • Sorafenib is crucial for managing advanced hepatocellular carcinoma.
    • The therapeutic arsenal for HCC requires expansion with novel agents.
    • Further research is vital to improve outcomes for liver cancer patients.

    More Related Videos

    An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

    An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

    Published on: September 12, 2019

    9.7K
    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

    Published on: May 24, 2024

    1.5K

    Related Concept Videos

    Clinical Trials01:16

    Clinical Trials

    Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
    There are four phases in a clinical trial. A phase one...
    11.2K
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    5.5K